- Filed
- Jul 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jul 23, 2025 | 955.38M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 977M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 988M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 1.05B sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 1.06B sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $3.05B |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $3B |
| Capex | Q2 2025 · Jun 30, 2025 | $402M |
| Capex | Q2 2025 · Jun 30, 2024 | $311M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $2.06B |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $3.44B |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $11.3B |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $9.88B |
| Short Term Investments | Q2 2025 · Jun 30, 2025 | $3.32B |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $4.26B |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $6.69B |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $6.66B |
| Cash And Equivalents restated | Q2 2025 · Jun 30, 2024 | $7.8B |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $20.2B |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $20.25B |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $20.42B |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $20.62B |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $20.7B |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $21.05B |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $45.05B |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $45.49B |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $59.58B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $58.31B |
| Current Assets | Q2 2025 · Jun 30, 2025 | $59.88B |
| Current Assets | Q2 2025 · Dec 31, 2024 | $58.21B |
| Total Assets | Q2 2025 · Jun 30, 2025 | $79.78B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $78.73B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $1.29 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $2.58 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $1.08 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $1.90 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $1.30 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $2.61 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $1.08 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $1.91 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $461M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $964M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $570M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $1.03B |
| Net Income | Q2 2025 · Jun 30, 2025 | $1.26B |
| Net Income | Q2 2025 · Jun 30, 2025 | $2.55B |
| Net Income | Q2 2025 · Mar 31, 2025 | $1.29B |
| Net Income | Q2 2025 · Jun 30, 2024 | $1.13B |
| Net Income | Q2 2025 · Jun 30, 2024 | $2.02B |
| Net Income | Q2 2025 · Mar 31, 2024 | $888M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $1.5B |
| Operating Income | Q2 2025 · Jun 30, 2025 | $3.03B |
| Operating Income | Q2 2025 · Jun 30, 2024 | $1.33B |
| Operating Income | Q2 2025 · Jun 30, 2024 | $2.49B |